SAN JOSE, Calif.–(BUSINESS WIRE)–Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that She will host a webinar for patients and physicians on her Tablo® Hemodialysis System for use in home dialysis on Wednesday, June 1, 2022 at 1:00 p.m. PT / 4:00 p.m. ET.
The live webinar, aimed at investment professionals, will feature a panel discussion moderated by Michael Aragon, MD, Outset Medical Director, between Tablo home dialysis patients and Varshi Broumand, MD, MHA, FACP, FASN , medical director of dialysis at CHRISTUS Santa Rosa Health System and nephrologist at the South Texas Renal Care Group. The discussion will focus on the patient’s care journey to home dialysis and each home dialysis patient’s experience with Tablo.
A live Q&A session will follow. To register for the event, please click here.
A live and archived webcast of the webinar will be available in the “Investors” section of Outset’s website at https://investors.outsetmedical.com/.
About Outset Medical, Inc.
Outset is a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis. The Tablo hemodialysis system, cleared by the FDA for hospital-to-home use, represents a significant technological advancement that transforms the dialysis experience for patients and operationally simplifies it for providers. Tablo serves as a single enterprise solution that can be used across the continuum of care, allowing dialysis to be administered anytime, anywhere, by anyone. The integration of water purification and on-demand dialysate production enables Tablo to serve as a dialysis clinic on wheels, with two-way wireless data transmission and a proprietary data analysis platform fueling a new holistic approach to dialysis care. Tablo is a registered trademark of Outset Medical, Inc.